Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

Compare

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MAXHEALTH Analyst Ratings

Moderate Buy

1 Buy

2 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Max

Healthcare Institute Ltd

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MAXHEALTH Stock 12 Month Forecast

Average Price Target

₹1,213.33

▼(-4.26% Downside)

Based on 3 Wall Street analysts offering 12 month price targets for Max Healthcare Institute Ltd in the last 3 months. The average price target is ₹1,213.33 with a high forecast of ₹1,325.00 and a low forecast of ₹1,145.00. The average price target represents a -4.26% change from the last price of ₹1,267.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"749":"₹749","1326":"₹1,326","893.25":"₹893.3","1037.5":"₹1,037.5","1181.75":"₹1,181.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.32K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1213.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.21K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1145,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.15K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[749,893.25,1037.5,1181.75,1326],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Feb<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1278.12,1281.7261538461537,1285.3323076923075,1288.9384615384615,1292.5446153846153,1296.1507692307691,1299.756923076923,1303.363076923077,1306.9692307692308,1310.5753846153846,1314.1815384615384,1317.7876923076924,1321.3938461538462,{"y":1325,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1278.12,1273.1361538461538,1268.1523076923077,1263.1684615384615,1258.1846153846152,1253.200769230769,1248.216923076923,1243.2330769230769,1238.2492307692307,1233.2653846153846,1228.2815384615383,1223.2976923076922,1218.313846153846,{"y":1213.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1278.12,1267.8799999999999,1257.6399999999999,1247.3999999999999,1237.1599999999999,1226.9199999999998,1216.6799999999998,1206.44,1196.2,1185.96,1175.72,1165.48,1155.24,{"y":1145,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":750.04,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":952.3,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":921.59,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":880.73,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":967.88,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1015.48,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1018.47,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1018.47,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1138.24,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1061.02,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":977.72,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1094.94,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1278.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹1,325

Average Price Target₹1,213

Lowest Price Target₹1,145

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

₹1,436

Buy

13.31%

Upside

07/08/25

Max Healthcare Institute Ltd shows strong financial performance with substantial revenue growth and profitability, supporting the stock's appeal. However, high valuation metrics and technical indicators pointing to potential overbought conditions temper enthusiasm. The absence of significant earnings call data and corporate events limits further evaluation.

Damayanti KeraiHSBC

HSBC

₹1,055→₹1,145

Hold

-9.65%

Downside

Reiterated

07/17/25

HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)

Bansi DesaiJ.P. Morgan

J.P. Morgan

₹1,390→₹1,325

Buy

4.55%

Upside

Reiterated

05/22/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.

Neha ManpuriaBank of America Securities

Bank of America Securities

₹1,100→₹1,170

Hold

-7.68%

Downside

Reiterated

05/21/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.

Kunal DhameshaMacquarie

Macquarie

₹615

Sell

-51.47%

Downside

Reiterated

03/28/25

Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).

Alankar GarudeKotak Mahindra

Kotak Mahindra

₹975→₹1,020

Sell

-19.51%

Downside

Reiterated

02/03/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,020 at KotakKotak analyst Alankar Garude raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,020.00 (from INR975.00) while maintaining a Reduce (3) rating.

Alok DalalJefferies

Jefferies

₹1,250→₹1,380

Buy

8.89%

Upside

Reiterated

01/10/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,380 at JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,380.00 (from INR1,250.00) while maintaining a Buy rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

₹1,436

Buy

13.31%

Upside

07/08/25

Damayanti KeraiHSBC

HSBC

₹1,055→₹1,145

Hold

-9.65%

Downside

Reiterated

07/17/25

HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)

Bansi DesaiJ.P. Morgan

J.P. Morgan

₹1,390→₹1,325

Buy

4.55%

Upside

Reiterated

05/22/25

Neha ManpuriaBank of America Securities

Bank of America Securities

₹1,100→₹1,170

Hold

-7.68%

Downside

Reiterated

05/21/25

Kunal DhameshaMacquarie

Macquarie

₹615

Sell

-51.47%

Downside

Reiterated

03/28/25

Alankar GarudeKotak Mahindra

Kotak Mahindra

₹975→₹1,020

Sell

-19.51%

Downside

Reiterated

02/03/25

Alok DalalJefferies

Jefferies

₹1,250→₹1,380

Buy

8.89%

Upside

Reiterated

01/10/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Max Healthcare Institute Ltd

1 Month

xxx

Success Rate

2/2 ratings generated profit

Average Return

+11.85%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +11.85% per trade.

3 Months

xxx

Success Rate

2/2 ratings generated profit

Average Return

+6.90%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.90% per trade.

1 Year

Bansi DesaiJ.P. Morgan

Success Rate

2/2 ratings generated profit

Average Return

+15.25%

reiterated a buy rating 3 months ago

Copying Bansi Desai's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.25% per trade.

2 Years

xxx

Success Rate

2/2 ratings generated profit

Average Return

+15.25%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +15.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MAXHEALTH Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

May 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MAXHEALTH has received 5 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. MAXHEALTH average Analyst price target in the past 3 months is 1,213.33.

Each month's total comprises the sum of three months' worth of ratings.

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

Next quarter’s earnings estimate for MAXHEALTH is ₹3.81 with a range of ₹3.60 to ₹4.00. The previous quarter’s EPS was ₹4.00. MAXHEALTH beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.44% of the time in the same period. In the last calendar year MAXHEALTH has Outperformed its overall industry.

MAXHEALTH Sales Forecast

Next quarter’s sales forecast for MAXHEALTH is ₹24.17B with a range of ₹23.26B to ₹24.98B. The previous quarter’s sales results were ₹19.10B. MAXHEALTH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.92% of the time in the same period. In the last calendar year MAXHEALTH has Preformed in-line its overall industry.

MAXHEALTH Stock Forecast FAQ

What is IN:MAXHEALTH’s average 12-month price target, according to analysts?

Based on analyst ratings, Max Healthcare Institute Ltd’s 12-month average price target is 1,213.33.

What is IN:MAXHEALTH’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for IN:MAXHEALTH, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Max Healthcare Institute Ltd a Buy, Sell or Hold?

Max Healthcare Institute Ltd has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 2 hold ratings and 0 sell ratings.

What is Max Healthcare Institute Ltd’s share price target?

The average share price target for Max Healthcare Institute Ltd is 1,213.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,325.00 ,and the lowest forecast is ₹1,145.00. The average share price target represents -4.26% Decrease from the current price of ₹1,267.3.

What do analysts say about Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of Max Healthcare Institute Ltd?

To buy shares of IN:MAXHEALTH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

MAXHEALTH Analyst Ratings

MAXHEALTH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Max Healthcare Institute Ltd

MAXHEALTH Analyst Recommendation Trends

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

MAXHEALTH Sales Forecast

MAXHEALTH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts